Conduit to Change Name to CDT Equity Inc.
Name change to CDT Equity Inc. reflects evolution of strategy and focus on identifying, enhancing, and advancing high-potential therapeutic assets...
Clinical Trial
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
Acquisition to Include DANYELZA® (Naxitamab-gqgk), Further Broadening SERB’s Rare Oncology Product PortfolioTransaction Expands SERB’s Investment in the U.S.SERB to Commence...
Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)...
Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
IRB Approval from Hadassah Medical Center Follows FDA IND Clearance and Prior Approvals from Additional Clinical Sites Vancouver, Canada, Aug....
Will DEA Cole Dismantle Marijuana Research Blockade – MMJ Biopharma Will Be His First Test Case
Terry Cole's future as DEA Administrator depends on recognizing the difference between cartels trafficking illicit fentanyl and MMJ's BioPharma Cultivation...
BioNxt Solutions Reports Pending Patent Grants in Europe and Eurasia, Strengthening IP Protection for Proprietary Sublingual Cladribine-Based MS Treatment
VANCOUVER, BC / ACCESS Newswire / August 5, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE: BNXT)(OTC PINK:BNXTF)(FSE:BXT), a...
Long Covid Patients Can Sign up for Remote Clinical Trial Notification, Announces CareEvolution
At-home participation in a study by Scripps Research and Schmidt Initiative for Long Covid powered by CareEvolution’s MyDataHelps® platformANN ARBOR,...
First-Ever Comparative Study of Hypothermic Oxygenated Machine Perfusion (HOPE) with Normothermic Machine Perfusion (NMP) in Liver Transplantation Shows Better Outcomes With HOPE
New data presented during Plenary Session at World Transplant Congress in San Francisco demonstrates HOPE improved graft and recipient survival...
Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement
VANCOUVER, BC / ACCESS Newswire / August 4, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased...
Dxcover Strengthens Leadership with World-Class Scientific Advisors and Board Members
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,...
Dxcover Strengthens Leadership with World-Class Scientific Advisors and Board Members
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,...
Digital Therapeutics Market to Grow at a CAGR of 26.3% from 2025 to 2032 | SkyQuest Technology Consulting
The digital therapeutics market is anticipated to increase due to the growing global burden of chronic conditions such as diabetes,...
Advarra Appoints Brian Hart as Chief Technology Officer
Former Covera Health CTO to Lead Technology and Product Strategy, Driving Innovation in Clinical Research COLUMBIA, Md., Aug. 4, 2025...
The Hidden Lung Infection Impacting Millions: World NTM Day Puts Spotlight on Awareness
With Annual NTM Case Rates Rising, Patients and Providers Are Urged to Recognize the Symptoms and Risks MIAMI, Aug. 4,...
Rapid Dose Therapeutics Submits QuickStrip(TM) Nicotine Product for Health Canada Approval
Innovative Oral Nicotine Delivery Technology Targets Safer Alternative for SmokersBurlington, Ontario--(Newsfile Corp. - August 4, 2025) - Rapid Dose Therapeutics...
Munchkin Revolutionizes Breastfeeding Support with Groundbreaking Innovation Backed by New Clinical Research
Coinciding with National Breastfeeding Awareness Month, new U.S. clinical research study shows 87% of moms using Munchkin’s Flow Nipple Shield+...
CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitopePhase 1 study in adults with active and...
Phase 1 Clinical Ttrial of HIV Vaccine Starts in Africa to Evaluate Immune Responses to Highly Networked HIV T-Cell Epitopes
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given....
Corporate Update, August 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM) Dear Shareholders, Thank...
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
Expansion adds additional AlterG dealer coverage to 6 countries throughout the Gulf Cooperation Council regionMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel,...